It is a form of autologous cellular immunotherapy that consists of peripheral blood mononuclear cells, cytokine granulocyte macrophage colony stimulating factor (GM-CSF), and immunosurveillance of the tumor antigen-prostatic acid phosphatase (PAP) [54, 57]. The gene discussed is ACP3; the disease is neoplasm.